Your browser doesn't support javascript.
loading
Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia.
Piñeyroa, Juan A; Magnano, Laura; Rivero, Andrea; Rivas-Delgado, Alfredo; Nadeu, Ferran; Correa, Juan Gonzalo; Giné, Eva; Villamor, Neus; Filella, Xavier; Colomer, Dolors; López, Mònica; López-Oreja, Irene; Costa, Dolors; Aymerich, Marta; Beà, Sílvia; López-Guillermo, Armando; Campo, Elías; Delgado, Julio; Mozas, Pablo.
Afiliação
  • Piñeyroa JA; Department of Hematology, Hospital Clínic, Barcelona, Spain.
  • Magnano L; Department of Hematology, Hospital Clínic, Barcelona, Spain.
  • Rivero A; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Rivas-Delgado A; Department of Hematology, Hospital Clínic, Barcelona, Spain.
  • Nadeu F; Department of Hematology, Hospital Clínic, Barcelona, Spain.
  • Correa JG; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Giné E; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • Villamor N; Department of Hematology, Hospital Clínic, Barcelona, Spain.
  • Filella X; Department of Hematology, Hospital Clínic, Barcelona, Spain.
  • Colomer D; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • López M; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • López-Oreja I; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Costa D; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • Aymerich M; Department of Pathology, Hematopathology Unit, Hospital Clínic, Barcelona, Spain.
  • Beà S; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • López-Guillermo A; Department of Biochemistry and Molecular Genetics, Hospital Clínic, Barcelona, Spain.
  • Campo E; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Delgado J; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • Mozas P; Department of Pathology, Hematopathology Unit, Hospital Clínic, Barcelona, Spain.
Hematol Oncol ; 40(4): 588-595, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35611996
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article